Garcinia gardneriana is chemically characterized by the presence of biflavonoids. Taking into account that flavonoids are able to inhibit monoamine oxidase (MAO) activity, in the present study, the chemical composition of the branches' extract of the plant is described for the first time and the MAO inhibitory activity of the isolated biflavonoids was evaluated. Based on spectroscopic and spectrometric data, it was possible to identify volkesiflavone, morelloflavone (1), Gb-2a (2) and Gb-2a-7-O-glucoside (3) in the ethyl acetate fraction from ethanol extract of the branches. Compounds 1-3 were evaluated in vitro and demonstrated the capacity to inhibit MAO-A activity with an IC 50 ranging from 5.05 to 10.7 µM, and from 20.7 to 66.2 µM for MAO-B. These inhibitions corroborate with previous IC 50 obtained for monomeric flavonoids, with a higher selectivity for MAO-A isoform. The obtained results indicate that biflavonoids might be promising structures for the identification of new MAO inhibitory compounds.
Several biological activities had already been reported for different species of Garcinia L., such as anti-inflammatory, antioxidant, and antitumor [1] [2] [3] . Garcinia gardneriana (Planch. & Triana) Zappi (Guttiferae) (=Rheedia gardneriana Planch. & Triana) is a tree widely distributed on the Brazilian Atlantic Forest biome and easily cultivated [4] . It is popularly known as "bacupari" in the South of Brazil and it is traditionally used for the treatment of infections and various types of pain and inflammation [5] . Regarding the chemical composition, different classes of secondary metabolites had already been isolated from diverse organs of the species, including terpenoids, steroids and phenolic compounds. Concerning the leaves, biflavonoids core compounds have been described, including volkensiflavone, GB-2a, morellofavone (or fukugetin) and fukugeside [6] .
Studies have determined that certain flavonoids and related synthetic compounds are potentially MAO inhibitors. It has already been described the MAO inhibitory properties of luteolin (MAO-A IC 50 4.9 µM, MAO-B IC 50 59.7 µM), apigenin (MAO-A IC 50 1.7 µM, MAO-B IC 50 12.8 µM) and quercetin (MAO-A IC 50 2.8 µM, MAO-B IC 50 90.0 µM) [7] . The flavonoids quercitrin, isoquercitrin, rutin and quercetin isolated from Melastoma candidum D. were also evaluated as MAOIs with IC 50 values for MAO-B of 6.19, 11.64, 10.89 and 3.89 µM respectively. These flavonoids also demonstrated antioxidant activity [8] . Most of the flavonoids are more selective to MAO-A. Chaurasiya et al. [9] demonstrated that galangin, apigenin, and quercetin were able to inhibit MAO-A activity with an IC 50 ranging from 0.13 to 2.44 µM, being 2 to 28 times more selective to this enzyme in comparison to the MAO-B isoform. This selectivity corroborates with the study of Chimenti et al. [7] .
The extent of MAO activity is associated with various behavioral abnormalities. Inhibition of MAO-A predominantly affects neurotransmitters considered to be important in depression and anxiety disorders. On the other hand, MAO-B inhibitors would increase the basal dopamine levels in the nigrostriatal dopaminergic input pathway [10] , that is the reason why MAO-B inhibitors are used for the symptomatic treatment of Parkinson's Disease, such as the N-propargyl drugs [11] . Both isozymes seem to also be involved in the etiology of Alzheimer's Disease (AD). There are some reports of increased MAO-B activity in the hippocampus and cerebral cortex of patients with AD. Changes in MAO-A appear to be more complex, since increased enzymatic activity or increased expression of mRNA are observed in a large number of brain regions, including the neocortex of the frontal lobe, the parietal cortex, occipital cortex, temporal cortex and frontal cortex [12] .
Although the focus of studies on the involvement of MAO inhibitors in neuroprotection has been on MAO-B inhibitors, there are growing evidences demonstrating that MAO-A inhibitors may also have neuroprotective properties. Thus, the presence of MAO inhibitors in plants extracts suggest that such preparations may be investigated for neurodegenerative diseases. Selective MAO-A inhibitors may also exert protective effects, such as moclobemide, a reversible MAO-A inhibitor, that has been reported to have anti-Parkinson activity and neuroprotective effects in a model of cerebral ischemia [7] .
Taking into account that Garcinia biflavonoids had already demonstrated antioxidant properties and that several monomeric flavonoids display MAO inhibitory potential, this study deals with the evaluation of the effect of a G. gardneriana biflavonoid enriched fraction and isolated biflavonoids on MAO-A and -B activities. Moreover, the chemical characterization of the extract and isolated biflavonoids are achieved by HPLC-DAD, UPLC-DAD-MS and NMR analysis.
In previous studies of Garcinia gardneriana, biflavonoids were isolated from the leaves [4, 6, [13] [14] [15] . The leaves have been focus of studies since it is used in folk Brazilian medicine because of its antiinflammatory activity. However, bark and seeds have also been evaluated due to their anti-inflammatory activity, but no promising results were obtained. Preliminary phytochemical investigation of the bark and seeds extracts compared with that obtained from the leaves indicated a significant difference in the chemical composition, with lower biflavonoids content for the formers [14] . Xanthones have also been described for the roots [16] . In the present study, the branches were used for chemical and pharmacological analysis, taking into account that, as far as we know, no previous studies were performed with this part of the plant.
After ethanol extraction, the calculated yield was 14%. The partition with different solvents afforded the fractions hexane (yield 15%), dichloromethane (yield 29%) and ethyl acetate (yield 43.5%), and the remaining corresponding to the aqueous fraction. Each fraction was analyzed by TLC. For hexane and dichloromethane fractions, similar bands corresponding to terpenoids and steroids were observed, unlike the fraction of ethyl acetate in which it was detected different bands corresponding to phenolic compounds. Considering that there are some reports demonstrating that phenolic compounds, such as flavonoids, are able to inhibit MAO activity [17] , the ethyl acetate fraction of G. garneriana was evaluated by in vitro assay. It was observed that the fraction was able to impair MAO-A and -B activities in the same extend, with an IC 50 of about 22 μg/mL. Aiming to identify the compounds responsible for this activity, the fraction was analyzed. The HPLC analysis of the fraction also indicated the presence of phenolic compounds, corroborating with results observed by TLC. By the UV profile of the different peaks, it was possible to infer the presence of flavonoids in the fraction. Taking into account that HPLC-DAD analysis is not sufficient to identify the compounds, the same fraction was injected in an UPLC-DAD-MS equipment in order to perform a deeper analysis of the chemical profile of the fraction. By the fragmentation of some peaks, it was possible to observe different pseudo-molecular ions [M+H] + at 557, 559, and 541. With the calculation and comparison of corresponding mass data of these compounds, they were identified as:
Morelloflavone (1) (Figure 1 ). Since these biflavonoids have already been isolated from G. gardneriana leaves previously [6] , these compounds were co-injected with authentic samples, affording the same retention time. Therefore, based on UV spectra, retention time and mass data, it was possible to confirm the structure of the biflavonoids.
In addition to the already described biflavonoids (1)-(2), another compound (3) was isolated from the ethyl acetate fraction by column chromatography. By HPLC-DAD analysis, it was possible to observe that the UV profile had the same profile as that exhibited by Gb-2a. However, by UPLC-MS analysis, a molecular ion peak at 740 was observed with a base peak at 559, the same observed for Gb-2a. Taking into account the difference of 180, a Gb-2a glucose structure was proposed. By NMR analysis and comparison with spectral data [18, 19] , the structure of Gb-2a-7-O-glucoside (3) was confirmed ( Figure 1 ).
Aiming to evaluate if these biflavonoids have the capacity to inhibit MAO activity, morelloflavone (1), Gb-2a (2) and Gb-2a-7-Oglucoside (3) were submitted to in vitro evaluation.
As observed in table 1, these compounds were more selective to MAO-A, with IC 50 ranging from 5.05 to 10.7 µM in comparison to 20.7 to 66.2 µM for MAO-B. This might be due to the smaller entrance cavity (290 A³) and substrate cavity for MAO-B (~400 A³) when compared to the monopartite cavity of the MAO-A enzyme (~550 A³) [20] . In addition, the lack of selectivity of the ethyl acetate fraction can be justified because additional products seem to be present. These unknown compounds probably play an important role as MAO-B inhibitors, explaining the different results. Extraction and isolation: Ethanol extraction 1:10 was performed by maceration of the dried branches (82g), three consecutive times for periods of 48 hours. This extract was suspended in water and partitioned with hexane (1.71g), dichloromethane (3.33g) and ethyl acetate (4.99g). At the end, each solvent was evaporated by rotary evaporator under vacuum.
The ethyl acetate fraction was subjected to column chromatography using silica gel as stationary phase. As eluent, a gradient of dichloromethane/methanol was used, ranging from 100:0 until 0:100, changing 10% each 300 mL. This volume was selected based on the dimension of the column. In addition, fractions were collected each 10 mL. Subsequently, fractions were analyzed by TLC and similar fractions were reunited. Fractions F2 and F3 were again submitted to column chromatography using the same solvent mixture, however ranging from 95:5 to 70:30, changing 5% each 100 mL. Compound 1 was isolated with 2.0% of yield by column chromatography from fraction F3 using a triphasic gradient of dichloromethane/acetone/methanol. F2 was submitted to column chromatography using a gradient solvent of dichloromethane/acetone obtaining the fraction 2-82. Finally, the fraction 2-82 (107mg) was recromatographed using an isocratic elution of dichloromethane/ethyl acetate/methanol (70:15:15, v/v/v), affording compound 3 (4.8% yield). These compounds were analyzed by NMR and the spectra compared to those already reported in the literature. Compound 2 (Gb-2a) was previously isolated, as described by Luzzi et al. [6] .
Chromatographic analyses Sample dilution and preparation:
Sample solutions were prepared by dissolving the compounds and fraction in HPLC grade MeOH. For the HPLC analysis the samples and mobile phases were filtered under vacuum using a 0.45 μm Millipore membrane filter. For the UPLC analysis, the samples were filtered using 0.22 µm membrane filter. Sonication was performed for 20 minutes in order to eliminate air bubbles. The ethyl acetate fraction was co-injected with the reference samples of biflavonoids (1)-(3). All the samples were injected at 1 mg/mL.
HPLC-DAD and UPLC-MS conditions:
The ethyl acetate fraction and isolated biflavonoids were analyzed by HPLC-DAD and UPLC-DAD-MS. For the method development in analytical HPLC, o-phosphoric acid 0.1% in water (phase A) and o-phosphoric acid 0.1% in acetonitrile (phase B) as a mobiles phases were evaluated.
A column Kromasil ® C 18 , (15cm x 4,6mm, 5µm particle (100 Å pore size)) was selected. The flow rate was set at 0.70 mL/min and the injection volume at 10µL. After optimization, the samples were analyzed by gradient elution: 78%A-22%B (0-20min), 74%A-26%B (20-60 min), 60%A-40%B at 60 minute, 40%A-60%B at 80 minute and 0%A-100%B (82-87 min). The chromatograms were monitored at 254 nm. Data analysis was performed with Empower ™ Software.
For UPLC-DAD-MS analysis, a column ACQUITY UPLC ® BEH C 18 1.7µm, 2.1x50mm conditioned at 30 °C was used. The analysis was performed in positive ion mode in a range m/z 100-1000, capillary voltage 3000V, cone voltage 30v, extraction Cone 3.3V, source temperature 100°C, and desolvation temperature 250°C. The solvent system was the same as described for HPLC, however with a different gradient: Initial 78%A-22%B (0-2.15min), 76%A-24%B (2.15-6.69 min), 60%A-40%B (7.82 min), 40%A-60%B (8.95 min), 0%A-100%B (9.18-9.75 min). The data analysis was performed with Software MassLynx ™ 4.1.
MAO inhibitory assay:
MAO inhibitory assay was performed using human recombinant MAO-A or MAO-B [21] . The assays were carried out in black polystyrene 96-well microtiter plates. The plates were preincubated for 20 minutes at 37 °C with 158 µL of potassium phosphate buffer pH 7.4, 2 µL of the sample diluted in DMSO and 20 µL of kynuramine 0.5 mM. Later, it was added 20 µL of the enzyme (MAO-A 0.09 mg/mL or MAO-B 0.15 mg/mL) and, after the incubation (30 min at 37°C), 75 µL of NaOH 1M was used to stop the reaction. As control, it was used DMSO 1% and clorgyline 10 -6 M (100% of inhibition) and 10 -8 M (50% of inhibition) for MAO-A, or pargyline 10 -5 M (100% of inhibition) and 10 -7 M (50% of inhibition) for MAO-B. Fluorescence readings were measured at an excitation wavelength of λ = 315 nm and an emission wavelength of λ = 380 nm. The extract was tested in concentrations ranging from 6 to 200 µg/mL and biflavonoids (1-3) were tested in concentrations ranging from 3 to 100 µM.
Statistical analysis:
Data analysis was performed with Prism 5.0 (GraphPad Software, Inc., CA, USA) and the IC 50 was calculated by adjusting the experimental data (% of inhibition versus concentration) to nonlinear regression curves.
